Efficacy of concomitant use of PUVA and methotrexate in disease clearance time in plaque type psoriasis

Journal of the Pakistan Medical Association

Volumn 54, Issue 9, 2004, Pages 453-455

  Shehzad, T ^a   Dar, N R ^a   Zakria, M ^b  

^a PNS SHIFA HOSPITAL   (Pakistan)

^b AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; PSORALEN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ERYTHEMA; HEMATOLOGIC DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; NAUSEA; PRURITUS; PSORIASIS VULGARIS; PUVA; RADIATION DOSE; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION;

ADOLESCENT; ADULT; COHORT STUDIES; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; PROBABILITY; PSORIASIS; PUVA THERAPY; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 6344285220     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Pal SS, Khurshid K, Zaman T. Efficacy of PUVA therapy in moderate and severe chronic plaque psoriasis. Prof Med J 1999;6:542-6.
2. Stern RS. The risk of melanoma in association with long term exposure to PUVA. J Am Acad Dermatol 2001;44:755-61.
3. Morison WL. Phototherapy and photochemotherapy. In: Phototherapy and photochemotherapy of skin disease, 2nd ed. New York: Raven Press; 1991 pp. 3-5.
4. Zachariae H. Methotrexate therapy risk assessment for patient and dermatologist. Fitzpatrick's J Clin Dermatol 1993;1:14-20.
5. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988;124:869-71.
6. Timonen P. Psoriasis area and severity index. Br J. Dermatol 1990; 122 (Suppl 36):33-9.
7. Morrison, Khosro Momtaz K, Parish JA, Fitzpatrick TB. Combined methotrexate-PUVA therapy in the treatment of psoriasis. J Am Acad Dermatol 1982;6:46-51.